From Name

From Email

To Name

To Email

Message

Study explores if insurance is keeping pace with trends in targeted cancer therapy

from Medical Xpress

Study explores if insurance is keeping pace with trends in targeted cancer therapy Medical Xpress New research from the University of California, San Francisco (USCF) and City of Hope in the July 2020 issue of Journal of the National Comprehensive Cancer Network examines coverage trends for circulating tumor DNA testing, also known as gene sequencing of ctDNA or "liquid biopsies." CtDNA is formed when tumor cells shed cell-free DNA fragments containing valuable information for detecting the tumor's genetic attributes into the bloodstream. READ MORE

more